Shares of HIMS experienced a dramatic drop today following the click here unexpected withdrawal of its deal with pharmaceutical giant Novo Nordisk. Investors responded negatively to the news, sending HIMS's stock price plummeting by more than 10%. The reason for the breakdown of the partnership remains unclear, but industry analysts speculate that